Primary tumor location is a risk factor for postoperative development of sarcopenia as a predictive marker for unfavorable outcomes in patients with colorectal cancer
Authors:
- 26 April 2025
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 30 (7) , 1355-1364
Abstract
Background The impact of the skeletal muscle volume after colorectal cancer surgery is unclear. Thus, we investigated the change of skeletal muscle mass after surgery and its effects on long-term outcomes. Methods This retrospective analysis included clinical stage I-IV colorectal cancer patients who underwent curative resection between April 2012 and March 2014 in our hospital. The psoas muscle area at the third lumbar vertebra level was evaluated by computed tomography and was divided by the square of height to obtain the psoas muscle mass index (PMI). Sarcopenia was defined using the PMI cut-off values for Asian adults of 6.36 cm2/m2 for males and 3.92 cm2/m2 for females. Results Among eligible 354 patients, 166 and 145 had pre- and postoperative sarcopenia one year after surgery, respectively. Five-year disease-free survival (DFS) and overall survival (OS) rates were 81.7% and 94.5%, respectively. In multivariate analysis, postoperative sarcopenia was an independent risk factor for shorter DFS [hazard ratio (HR) 1.71, p = 0.0171] and OS (HR 2.42, p = 0.0455), respectively, but preoperative sarcopenia was not a prognosticactor for either. One year after colorectal resection, 24 patients (6.8%) were newly diagnosed with sarcopenia, while 45 (12.7%) recovered from sarcopenia. Rectal cancer was identified as an independent risk factor for the postoperative development of sarcopenia (odds ratio 3.12, p = 0.0440). Conclusion Postoperative sarcopenia one year after surgery was associated with poor DFS and OS. Thus, clinicians need to consider skeletal muscle loss during postoperative surveillance, particularly in rectal cancer patients without sarcopenia before surgery.Keywords
All Related Versions
Funding Information
- Grants-in-Aid for Scientific Research (C: grant number, 18K07194, C: grant number, 19K09114, C: grant number, 19K09115, C: grant number, 20K09051, Challenging Research, Exploratory: 20K21626, B: grant number, 21H02778)
- the Project for Cancer Research and Therapeutic Evolution (JP 19cm0106502)
This publication has 34 references indexed in Scilit:
- Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective studyInternational Journal of Clinical Oncology, 2021
- Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysisInternational Journal of Colorectal Disease, 2021
- Change in Skeletal Muscle Following Resection of Stage I–III Colorectal Cancer is Predictive of Poor Survival: A Cohort StudyWorld Journal of Surgery, 2019
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancerInternational Journal of Clinical Oncology, 2019
- Postoperative development of sarcopenia is a strong predictor of a poor prognosis in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancerThe American Journal of Surgery, 2019
- The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patientsJournal of Cachexia, Sarcopenia and Muscle, 2019
- Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric JunctionWorld Journal of Surgery, 2018
- Predictive Value of Preoperative Sarcopenia in Patients with Gastric Cancer: a Meta-analysis and Systematic ReviewJournal of Gastrointestinal Surgery, 2018
- Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinomaJournal of Hepato-Biliary-Pancreatic Sciences, 2015
- Long-term weight change after oesophageal cancer surgeryBritish Journal of Surgery, 2009